Stunting in under-five children with chronic kidney disease: Indian synthetic growth charts are more accurate than World Health Organization growth standards
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
Background: Accurate growth monitoring is critical in pediatric chronic kidney disease (CKD), where impaired linear growth is common. The WHO multicentre growth reference study (MGRS) 2006 standards are widely used but may overestimate stunting in Indian children due to ethnogenetic and environmental differences. Indian synthetic growth charts, developed using the LMS method and based on national data, may offer a more appropriate reference. This study compared stunting prevalence in under-five children with CKD using world health organization (WHO) standards and Indian synthetic growth charts. Methods: This cross-sectional observational study was conducted at a tertiary care centre in Pune, Maharashtra, over 18 months (January 2023-June 2024). A total of 120 term-born children aged 0-60 months with confirmed CKD were enrolled. Standardized anthropometric measurements of length/height were obtained. Length/height-for-age Z-scores were calculated using WHO AnthroPlus software and LMS values for Indian synthetic charts. Stunting was defined as a Z-score
Fields of Study & Subjects
Child Nutrition and Water Access
Growth Hormone and Insulin-like Growth Factors
Human Health and Disease
Publication details
- Journal / source
- International Journal of Contemporary Pediatrics
- Volume
- 13
- Issue
- 4
- Pages
- 593–599
- Publication date
- 25 March 2026
- Language
- EN